TY - JOUR T1 - Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY. AU - Ferm,Samson, AU - Fisher,Constantine, AU - Pakala,Tina, AU - Tong,Michelle, AU - Shah,Disha, AU - Schwarzbaum,David, AU - Cooley,Victoria, AU - Hussain,Syed, AU - Kim,Sang Hoon, Y1 - 2020/06/01/ PY - 2020/05/18/received PY - 2020/05/26/revised PY - 2020/05/27/accepted PY - 2020/6/5/pubmed PY - 2020/9/4/medline PY - 2020/6/5/entrez SP - 2378 EP - 2379.e1 JF - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association JO - Clin Gastroenterol Hepatol VL - 18 IS - 10 N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an RNA virus responsible for coronavirus disease 2019 (COVID-19).1,2 The virus enters cells via the angiotensin-converting enzyme 2 receptor, which is present in enterocytes in the ileum and colon.3 Gastrointestinal (GI) manifestations include diarrhea, nausea, vomiting, and abdominal pain, and the prevalence of GI symptoms varies greatly, with a range between 2% and 57%.4 In addition, abnormal liver chemistries are reported commonly.4 As a medical center at the forefront of the early epidemic in the United States, we seek to contribute to the growing body of literature that outlines the gastrointestinal and hepatic manifestations of COVID-19. SN - 1542-7714 UR - https://www.unboundmedicine.com/medline/citation/32497637/Analysis_of_Gastrointestinal_and_Hepatic_Manifestations_of_SARS_CoV_2_Infection_in_892_Patients_in_Queens_NY_ DB - PRIME DP - Unbound Medicine ER -